Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page
- Check4 days agoChange DetectedThe page footer revision label changed from v3.6.3 to v3.6.4, signaling a minor content update to the Study Details page. It does not affect the study information or how the page functions.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision banner updated from v3.6.2 to v3.6.3, indicating a minor internal update to the study page. It does not modify any study details, eligibility criteria, or results.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, representing a small software revision.SummaryDifference0.1%

- Check46 days agoChange DetectedEnrollment is no longer open to participants, and the page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) while updating the page revision to v3.6.0.SummaryDifference0.5%

- Check54 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor backend/template update. No study details, eligibility criteria, or locations were changed.SummaryDifference0.1%

- Check75 days agoChange DetectedFooter shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor site update.SummaryDifference0.1%

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.